Skip to main content
Log in

Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

A 56-year-old male with chronic renal failure was admitted to the hospital because of progressive hip pain, appetite loss, general fatigue, and hypercalcemia. Slight pain had developed in the left hip 3 months before the initiation of hemodialysis, which subsequently developed into hyperalgesia. The patient was suspected to have sarcoidosis based on the elevated serum angiotensin-converting enzyme and lysozyme levels, and the ocular finding characterized by punched out chorioretinal scarring, although this could not be confirmed by histological evaluations. There was an abnormal uptake of gallium in the dependent portion of the tumoral calcinosis, which could have suggested either the presence of granulomatous sarcoid tissue within the calcified mass or active calcification associated with an inflammatory reaction. Elevated serum concentrations of 1,25-dihydroxyvitamin D3, which should be implicated in the development of hypercalcemia, promptly decreased after the administration of steroids. Steroid administration subsequently led to a decrease in the serum calcium and relief of the hip pain. This was a rare case of sarcoidosis associated with symptomatic tumoral calcinosis and hypercalcemia. The diagnostic significance of a gallium scan in this case will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pecovnik-Balon B, Kramberger S. Tumoral calcinosis in patients on hemodialysis. Am J Nephrol. 1997;17:93–5.

    Article  CAS  PubMed  Google Scholar 

  2. Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K. Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a hemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant. 2000;15:1691–3.

    Article  CAS  PubMed  Google Scholar 

  3. Eisenberg B, Tzamaloukas AH, Hartshorne MF, Listrom MB, Arrington ER, Sherrard DJ. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. J Nucl Med. 1990;31:1099–103.

    CAS  PubMed  Google Scholar 

  4. Naito T, Nitta K, Kamita N, Honda K, Yoshida T, Koinuma M, et al. Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on hemodialysis treatment. Nephrol Dial Transplant. 1999;14:2716–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hodnett P, Moore M, Kinsella S, Kelly D, Plant WD, Maher MM. Radiological features of progressive tumoral calcinosis in chronic renal failure. Australas Radiol. 2007;51:B115–8.

    Article  PubMed  Google Scholar 

  6. Rima A, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology. 2001;221:455–61.

    Article  Google Scholar 

  7. Hammert WC, Lindsay LR. Tumoral calcinosis-or is it? A case report and review. Hand. 2009;4:119–22.

    Article  PubMed  Google Scholar 

  8. Rothova A. Ocular involvement in sarcoidosis. Br J Opthalmol. 2000;84:110–6.

    Article  CAS  Google Scholar 

  9. Johnson DG, Johnson SM, Harris CC, Piantadosi CA, Blinder RA, Coleman RE. Ga-67 uptake in the lung sarcoidosis. Radiology. 1984;150:551–5.

    CAS  PubMed  Google Scholar 

  10. Soudry G, Connoly LP, Treves ST. Ga-67 imaging of tumoral calcinosis associated with secondary hyperparathyroidism. Clin Nucl Med. 1996;21:68–9.

    Article  CAS  PubMed  Google Scholar 

  11. Israel HL, Goldstein RA. Frequency of disordered calcium metabolism in sarcoidosis. Postgrad Med J. 1970;46:468–70.

    Article  CAS  PubMed  Google Scholar 

  12. Conron M, Young C, Beynon C. Review calcium metabolism in sarcoidosis and its clinical implications. Rheumatology. 2000;39:707–13.

    Article  CAS  PubMed  Google Scholar 

  13. Monkawa T, Yoshida T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene expression in macrophages. Kidney Int. 2000;58:559–68.

    Article  CAS  PubMed  Google Scholar 

  14. Kalantar Zedeh K, Nuemayer HH, Wunsch PH, Luft FC. Hypercalcemia and sarcoidosis in an anephric dialysis patient. Nephrol Dial Transplant. 1994;9:829–31.

    Google Scholar 

  15. Brandi L, Daugaard H, Tvedegaard E. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron. 1989;53:194–200.

    Article  CAS  PubMed  Google Scholar 

  16. Baker LRI, Abrams SML, Roe CJ, Faugere MC, Fanti P, Subayti Y, et al. 1, 25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989;35:661–9.

    Article  CAS  PubMed  Google Scholar 

  17. Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, Slatopolsky E, et al. Kinetics of monocyte 1α-hydroxylase in renal failure. Am J Physiol. 1995;268:F746–53.

    CAS  PubMed  Google Scholar 

  18. Putkonen T, Hannuksela M, Halme H. Calcium and phosphorus metabolism in sarcoidosis. Acta Med Scand. 1965;177:327–35.

    CAS  PubMed  Google Scholar 

  19. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535–9.

    Article  CAS  PubMed  Google Scholar 

  20. Motoyama K, Inaba M, Emoto M, Morii H, Nishizawa Y. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med. 2002;41:449–52.

    Article  PubMed  Google Scholar 

  21. Crystal RG. Sarcoidosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principle of internal medicine 13th edn. New York: McGraw-Hill; 1994. p. 1679–84.

    Google Scholar 

  22. Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 2006;26:871–85.

    Article  PubMed  Google Scholar 

  23. Akimoto T, Saito O, Kotoda A, Nishino K, Umino T, Muto S, et al. A case of recurrent renal failure associated with metabolic alkalosis induced by protracted vomiting. Clin Exp Nephrol. 2006;10:279–83.

    Article  PubMed  Google Scholar 

  24. Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. 1995;43:531–6.

    Article  CAS  Google Scholar 

  25. Fogelman I, Mckillop JH, Cowden EA, Fine A, Boyce B, Boyle IT, et al. Bone scan findings in hypervitaminosis D: case report. J Nucl Med. 1977;18:1205–7.

    CAS  PubMed  Google Scholar 

  26. Ahmed M, Almahfouz A, Alarifi A, Nasser T, Alkahtani N, Dayel FA. Hyperparathyroidism secondary to vitamin D deficiency. Clin Nucl Med. 2003;28:413–5.

    Article  PubMed  Google Scholar 

  27. Lambrinoudaki L, Christodoulakos G, Botsis D. Bisphosphonate. Ann N Y Acad Sci. 2006;1092:397–402.

    Article  CAS  PubMed  Google Scholar 

  28. Gibbs CJ, Peacock M. Hypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J. 1986;62:937–8.

    Article  CAS  PubMed  Google Scholar 

  29. Wenzel C, Bartsch R, Hussian D, Pluschnig U, Locker GJ, Sevelda U, et al. Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Support Care Cancer. 2004;12:678–81.

    PubMed  Google Scholar 

  30. Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, et al. American society of clinical oncology 2007 Clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25:2464–72.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsu Akimoto.

About this article

Cite this article

Horikoshi, R., Akimoto, T., Meguro, D. et al. Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure. Clin Exp Nephrol 15, 154–158 (2011). https://doi.org/10.1007/s10157-010-0362-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0362-4

Keywords

Navigation